ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Wildermuth Fund Mutual Fund Investors to Secure Counsel Before Important Deadline in Securities Class Action – WESFX, WEFCX, WEIFX GlobeNewswire December 08, 2025 NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A (ticker: WESFX), Class C […]

NEW YORK CITY, NY / ACCESS Newswire / December 8, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Marex Group Plc ("Marex" or the "Company") (NASDAQ:MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NEW YORK CITY, NY / ACCESS Newswire / December 8, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Stride, Inc. ("Stride" or the "Company") (NYSE:LRN).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / December 8, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against MoonLake Immunotherapeutics ("Moonlake" or the "Company") (NASDAQ:MLTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / December 8, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Avantor, Inc. ("Avantor" or the "Company") (NYSE:AVTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / December 8, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against WPP Plc ("WPP" or the "Company") (NYSE:WPP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF)(“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced that it has received commitments for a private placement of 10.5% Senior Secured Notes due 2030 (the “Notes”) for aggregate gross proceeds of US$100.0 million (the “Offering”). The Notes, which will be issued at

LEGAL NOTICE If you purchased or paid for some or all of the purchase price of Stelara,a class action lawsuit may affect your rights. Yourrights maybeaffectedbyaclassactionlawsuitregarding thepricepaidforStelara by thirdpartypayorsfiledagainst DefendantsJohnson & Johnson and Janssen Biotech Inc. (together, “J&J” or “the Defendants”). The Court decided that this case should be certified as a class action on

(Other OTC:SCTH),(OTC US:SCTH), SecureTech Backing Enables AI UltraProd's U.S. Accessory Dwelling Unit Beachhead; 2026 Rollout and Expansion Strategy Roseville, Minnesota, Dec. 08, 2025 (GLOBE NEWSWIRE) — AI UltraProd, Inc. (“Ai UltraProd”, AIUP”, or “the Company”), a global leader in AI-driven industrial solutions specializing in robotic 3D printing and advanced intelligent manufacturing systems, and a wholly

Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemias Findings underscore potential to address unmet needs in multiple hematological malignancies, manufacturing innovation and advance patient care BOSTON, Dec. 08, 2025 (GLOBE NEWSWIRE) — Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today presented